EU Blow For Alzheimer’s Drug Leqembi; Eisai To Appeal

 
• By Neena Brizmohun
  
The Alzheimer’s disease drug Leqembi is already approved in the US, Japan, China, South Korea, Hong Kong and Israel • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet